Innovis Asset Management’s Elanco Animal Health ELAN Stock Holding History

Innovis Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$144K	Buy	+12,778	New	+$148K	0.06%	146

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Innovis Asset Management's ELAN Position: Q3 2023 in Review

Innovis Asset Management opened a new position in Elanco Animal Health (ELAN) in Q3 2023: 12,778 shares worth $144K. The stake represents 0.06% of the portfolio and ranks #146 among its holdings.

350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

Innovis Asset Management held 12,778 shares of Elanco Animal Health worth $144K as of Q3 2023.
Elanco Animal Health was a new Innovis Asset Management position in Q3 2023.
Elanco Animal Health made up 0.06% of Innovis Asset Management's portfolio in Q3 2023, its #146 holding.
350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.